Pharsight

Otrexup patents expiration

OTREXUP's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11446441 OTTER PHARMS Prefilled syringe injector
Jan, 2026

(2 years from now)

US9533102 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US9629959 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US8562564 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US8021335 OTTER PHARMS Prefilled syringe jet injector
Oct, 2026

(3 years from now)

US11684723 OTTER PHARMS Injector safety device
Mar, 2029

(5 years from now)

US9867949 OTTER PHARMS Injector safety device
Mar, 2029

(5 years from now)

US10709844 OTTER PHARMS Injector safety device
Mar, 2029

(5 years from now)

US9421333 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(6 years from now)

US8480631 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(6 years from now)

US8945063 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(6 years from now)

US8579865 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(6 years from now)

US11497753 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(6 years from now)

US8814834 OTTER PHARMS Injector safety device
May, 2031

(7 years from now)

Otrexup is owned by Otter Pharms.

Otrexup contains Methotrexate.

Otrexup has a total of 14 drug patents out of which 0 drug patents have expired.

Otrexup was authorised for market use on 11 October, 2013.

Otrexup is available in solution;subcutaneous dosage forms.

Otrexup can be used as subcutaneous injection of methotrexate.

The generics of Otrexup are possible to be released after 27 May, 2031.

Drugs and Companies using METHOTREXATE ingredient

Market Authorisation Date: 11 October, 2013

Treatment: Subcutaneous injection of methotrexate

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

OTREXUP family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic